Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy-Reference-Cited by-同舟云学术

Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy

Published:2015-11-25 Issue: Volume: Page:hyv175
ISSN:0368-2811
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:Jpn. J. Clin. Oncol.

Author:

Zeng Yue-Can,Chi Feng,Xing Rui,Xue Ming,Wu Li-Na,Tang Mei-Yue,Wu Rong

Funder

National Natural Science Foundation of China

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/46/2/126/7195621/hyv175.pdf

Reference19 articles.

1. Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer

2. Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

3. Cancer-related inflammation

4. Hallmarks of Cancer: The Next Generation

5. Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of anemia and high neutrophil-lymphocyte ratio with decreased survival in patients with laryngeal cancer treated with radiotherapy;Anatolian Current Medical Journal;2023-07-28

2. Role and research progress of hematological markers in laryngeal squamous cell carcinoma;Diagnostic Pathology;2023-04-20

3. Prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in laryngeal cancer: What should we expect from a meta-analysis?;Frontiers in Oncology;2022-08-10

4. Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis: a retrospective study;European Archives of Oto-Rhino-Laryngology;2022-01-31

5. Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma;Oral Oncology;2021-05